197 related articles for article (PubMed ID: 2000634)
1. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
Plowchalk DR; Mattison DR
Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
[TBL] [Abstract][Full Text] [Related]
2. Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function.
Plowchalk DR; Mattison DR
Reprod Toxicol; 1992; 6(5):411-21. PubMed ID: 1463921
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries.
Desmeules P; Devine PJ
Toxicol Sci; 2006 Apr; 90(2):500-9. PubMed ID: 16381661
[TBL] [Abstract][Full Text] [Related]
4. Involvement of a volatile metabolite during phosphoramide mustard-induced ovotoxicity.
Madden JA; Hoyer PB; Devine PJ; Keating AF
Toxicol Appl Pharmacol; 2014 May; 277(1):1-7. PubMed ID: 24642057
[TBL] [Abstract][Full Text] [Related]
5. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
6. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
7. Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro.
Petrillo SK; Desmeules P; Truong TQ; Devine PJ
Toxicol Appl Pharmacol; 2011 Jun; 253(2):94-102. PubMed ID: 21439308
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
9. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
Zaharko DS; Covey JM; Hörpel G
Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508
[TBL] [Abstract][Full Text] [Related]
10. The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion.
Ganesan S; Keating AF
Toxicol Appl Pharmacol; 2016 Feb; 292():65-74. PubMed ID: 26708502
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic mechanisms in the selective toxicity of cyclophosphamide analogs and metabolites towards avian embryonic B lymphocytes in vivo.
Wilmer JL; Colvin OM; Bloom SE
Mutat Res; 1992 Jul; 268(1):115-30. PubMed ID: 1378178
[TBL] [Abstract][Full Text] [Related]
12. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramide mustard induces autophagy markers and mTOR inhibition prevents follicle loss due to phosphoramide mustard exposure.
Madden JA; Thomas PQ; Keating AF
Reprod Toxicol; 2017 Jan; 67():65-78. PubMed ID: 27888070
[TBL] [Abstract][Full Text] [Related]
14. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
15. Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro.
Lande Y; Fisch B; Tsur A; Farhi J; Prag-Rosenberg R; Ben-Haroush A; Kessler-Icekson G; Zahalka MA; Ludeman SM; Abir R
Reprod Biomed Online; 2017 Jan; 34(1):104-114. PubMed ID: 27815062
[TBL] [Abstract][Full Text] [Related]
16. A comparison of sister-chromatid exchange in mouse peripheral blood lymphocytes exposed in vitro and in vivo to phosphoramide mustard and 4-hydroxycyclophosphamide.
Bryant MF; Erexson GL; Kligerman AD
Mutat Res; 1989 Mar; 222(3):271-7. PubMed ID: 2922010
[TBL] [Abstract][Full Text] [Related]
17. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
Kishk EA; Mohammed Ali MH
Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
[TBL] [Abstract][Full Text] [Related]
18. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
[No Abstract] [Full Text] [Related]
19. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
20. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
